General Information
BounceWatch is an independent company data service, not affiliated with Invivoscribe. To contact Invivoscribe, visit invivoscribe.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Invivoscribe compare?
A PDF of Invivoscribe and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Invivoscribe soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Invivoscribe on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Invivoscribe
Business keywords: precision diagnostics, oncology, companion diagnostics, therapeutics, cGMP facility, clonal gene rearrangements, gene mutation testing, measurable residual disease, molecular testing, precision medicine, biopharma services, clinical diagnostics, flow cytometry, global healthcare
No funding data available for Invivoscribe yet.
Invivoscribe Alternatives & Competitors
View All AlternativesAdvancing precision medicine through next-generation liquid biopsy oncology platform
Companion Diagnostics for Precision Medicine in Oncology
High precision diagnostics for personalized medicine
FAQ About Invivoscribe
Source: BounceWatch company record for Invivoscribe, https://bouncewatch.com/company/invivoscribe, updated 30 December 2024. When citing, please name BounceWatch and link this page.